NCIt definition : A monoclonal antibody directed against the human T-cell-expressed receptor cytotoxic
T-lymphocyte-associated antigen 4 (CTLA4; CTLA-4), with potential immune checkpoint
inhibitory and antineoplastic activities. Upon administration, quavonlimab targets
and binds to CTLA4 expressed on T-cells and inhibits the CTLA4-mediated downregulation
of T-cell activation. This leads to a cytotoxic T-lymphocyte (CTL)-mediated immune
response against cancer cells. CTLA4, an inhibitory receptor and member of the immunoglobulin
superfamily, plays a key role in the downregulation of the immune system.;
UNII : GG0AN49Y59;
CAS number : 2254059-25-9; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2254059-25-9
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
Semantic type(s)